Discontinued — last reported Q4 '23
Geographic · Non-Current Assets
Other foreign countries — Non-Current Assets
Eli Lilly Other foreign countries — Non-Current Assets increased by 9.7% to $1.78B in Q4 2023 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2022
Last reportedQ4 2023
Rolls up toLong-Lived Assets
How to read this metric
An increase suggests ongoing capital investment or infrastructure expansion in these regions, whereas a decrease may reflect asset depreciation, divestitures, or a strategic shift in regional operational focus.
Detailed definition
This metric measures the book value of long-term assets, such as property, plant, equipment, and intangible assets, phys...
Peer comparison
Comparable to 'Non-current assets by geography' reported by multinational pharmaceutical peers, reflecting the regional distribution of manufacturing and research infrastructure.
Metric ID:
lly_segment_other_foreign_countries_noncurrent_assetsHistorical Data
3 periods
| Q4 '21 | Q4 '22 | Q4 '23 | |
|---|---|---|---|
| Value | $1.69B | $1.63B | $1.78B |
| QoQ Change | — | -3.8% | +9.7% |
| YoY Change | — | -3.8% | +9.7% |
Range$1.63B – $1.78B
Avg YoY Growth+2.9%
Median YoY Growth+2.9%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other foreign countries — non-current assets?
- Eli Lilly (LLY) reported other foreign countries — non-current assets of $1.78B in Q4 2023.
- What does other foreign countries — non-current assets mean?
- The total value of long-term, non-liquid assets held by the company in international markets outside of its primary reporting regions.